US Pharma MarketingAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
Artificial intelligence use cases across the federal health department spiked between fiscal years 2024 and 2025— led by a 148% year-over-year increase at the Food and Drug Administration (FDA), a There was a big uptick in the use of AI across all HHS agencies in 2025, though analysts note some use cases may “reflect new reporting requirements instead of new deployments." Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Trending Oncology Supply Chain AI and Machine Learning Awards Outsourcing Awards Innovation Awards Pharma…
There was a big uptick in the use of AI across all HHS agencies in 2025, though analysts note some use cases may “reflect new reporting requirements instead of new deployments."
Source: FiercePharma